tradingkey.logo

Nuwellis Inc

NUWE

3.540USD

-0.240-6.35%
Cierre 09/19, 16:00ETCotizaciones retrasadas 15 min
44.43KCap. mercado
PérdidaP/E TTM
Más Datos de Nuwellis Inc Compañía
Nuwellis, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
Información de la empresa
Símbolo de cotizaciónNUWE
Nombre de la empresaNuwellis Inc
Fecha de salida a bolsaFeb 16, 2012
Director ejecutivoErb (John L)
Número de empleados38
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 16
Dirección12988 Valley View Rd
CiudadEDEN PRAIRIE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal55344
Teléfono19523454200
Sitio Webhttps://www.nuwellis.com/
Símbolo de cotizaciónNUWE
Fecha de salida a bolsaFeb 16, 2012
Director ejecutivoErb (John L)
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Erb (John L)
Erb (John L)
Chairman of the Board, Interim President and Interim Chief Executive Officer
Chairman of the Board, Interim President and Interim Chief Executive Officer
803.00
--
Dr. Archelle (Feldshon) Georgiou, M.D.
Dr. Archelle (Feldshon) Georgiou, M.D.
Independent Director
Independent Director
3.00
--
Mr. David Alan (Dave) Mcdonald
Mr. David Alan (Dave) Mcdonald
Independent Director
Independent Director
3.00
--
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
--
--
Mr. Robert B. (Rob) Scott
Mr. Robert B. (Rob) Scott
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Neil P. Ayotte, Esq.
Mr. Neil P. Ayotte, Esq.
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
--
--
Dr. Maria Rosa Costanzo, M.D.
Dr. Maria Rosa Costanzo, M.D.
Independent Director
Independent Director
--
--
Mr. Michael (Mike) Mccormick
Mr. Michael (Mike) Mccormick
Lead Independent Director
Lead Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Erb (John L)
Erb (John L)
Chairman of the Board, Interim President and Interim Chief Executive Officer
Chairman of the Board, Interim President and Interim Chief Executive Officer
803.00
--
Dr. Archelle (Feldshon) Georgiou, M.D.
Dr. Archelle (Feldshon) Georgiou, M.D.
Independent Director
Independent Director
3.00
--
Mr. David Alan (Dave) Mcdonald
Mr. David Alan (Dave) Mcdonald
Independent Director
Independent Director
3.00
--
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
--
--
Mr. Robert B. (Rob) Scott
Mr. Robert B. (Rob) Scott
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Neil P. Ayotte, Esq.
Mr. Neil P. Ayotte, Esq.
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: sáb., 16 de ago
Actualizado: sáb., 16 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Sabby Management, LLC
0.67%
Bigger Capital Funds, LP
0.63%
UBS Financial Services, Inc.
0.36%
Geode Capital Management, L.L.C.
0.17%
XTX Markets LLC
0.08%
Otro
98.09%
Accionistas
Accionistas
Proporción
Sabby Management, LLC
0.67%
Bigger Capital Funds, LP
0.63%
UBS Financial Services, Inc.
0.36%
Geode Capital Management, L.L.C.
0.17%
XTX Markets LLC
0.08%
Otro
98.09%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
0.84%
Hedge Fund
0.72%
Investment Advisor
0.36%
Venture Capital
0.08%
Research Firm
0.02%
Individual Investor
0.02%
Otro
97.96%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
27
9.97K
1.46%
+7.11K
2025Q1
26
140.31K
3.15%
+23.64K
2024Q4
25
113.78K
2.60%
+73.44K
2024Q3
29
65.32K
2.68%
+45.76K
2024Q2
28
42.02K
3.15%
+30.15K
2024Q1
26
9.25K
4.91%
+1.97K
2023Q4
26
6.22K
6.75%
+3.61K
2023Q3
35
1.28K
4.82%
-1.76K
2023Q2
36
1.31K
5.00%
-797.00
2023Q1
36
712.00
4.39%
-1.50K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Bigger Capital Funds, LP
5.69K
1.08%
+5.69K
--
Jun 09, 2025
UBS Financial Services, Inc.
99.00
0%
-454.00
-82.10%
Mar 31, 2025
Geode Capital Management, L.L.C.
816.00
0.02%
+83.00
+11.32%
Mar 31, 2025
XTX Markets LLC
422.00
0.08%
+422.00
--
Mar 31, 2025
Two Sigma Investments, LP
438.00
0.01%
+169.00
+62.83%
Mar 31, 2025
Erb (John L)
52.38K
1.1%
+52.38K
--
Jun 10, 2025
Tower Research Capital LLC
146.00
0%
+32.00
+28.07%
Mar 31, 2025
Morgan Stanley & Co. LLC
--
0%
-7.00
-100.00%
Dec 31, 2024
SBI Securities Co., Ltd.
9.00
0%
-4.00
-30.77%
Mar 31, 2025
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Dec 09, 2022
Merger
100→1
Dec 09, 2022
Merger
100→1
Fecha
Tipo
Relación
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Dec 09, 2022
Merger
100→1
Dec 09, 2022
Merger
100→1
Dec 09, 2022
Merger
100→1
Dec 09, 2022
Merger
100→1
Oct 17, 2020
Merger
30→1
Oct 17, 2020
Merger
30→1
Ver más
KeyAI